J2930 — Injection, methylprednisolone sodium succinate, up to 125 mg
J2930 is a HCPCS Level II code for injection, methylprednisolone sodium succinate, up to 125 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on March 31, 2024 and is not valid on new claims.
This code has been terminated
CMS terminated J2930 on March 31, 2024. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J2930
- Long descriptor
- Injection, methylprednisolone sodium succinate, up to 125 mg
- Short descriptor
- Methylprednisolone injection
- Added
- January 1, 1984
- Terminated
- March 31, 2024
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J2930
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2930 is not quite right, the correct code is very often within a few positions of it.
- J2840Injection, sebelipase alfa, 1 mg
- J2850Injection, secretin, synthetic, human, 1 microgram
- J2860Injection, siltuximab, 10 mg
- J2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
- J2910Injection, aurothioglucose, up to 50 mgterminated
- J2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919Injection, methylprednisolone sodium succinate, 5 mg
- J2920Injection, methylprednisolone sodium succinate, up to 40 mgterminated
- J2940Injection, somatrem, 1 mgterminated
- J2941Injection, somatropin, 1 mg
- J2950Injection, promazine hcl, up to 25 mg
- J2993Injection, reteplase, 18.1 mg
- J2995Injection, streptokinase, per 250,000 iuterminated
- J2997Injection, alteplase recombinant, 1 mg
- J2998Injection, plasminogen, human-tvmh, 1 mg
- J3000Injection, streptomycin, up to 1 gm
Questions about J2930
What is HCPCS code J2930?
J2930 is a HCPCS Level II code for injection, methylprednisolone sodium succinate, up to 125 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J2930?
The CMS HCPCS file marks J2930 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J2930 still valid?
No. J2930 was terminated on March 31, 2024 and should not be used on new claims.